NeuExcell Therapeutics Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
NeuExcell Therapeutics Inc. - overview
Established
2021
Location
Shanghai, Shanghai, China
Primary Industry
Biotechnology
About
Based in China, and established in 2021, NeuExcell Therapeutics Inc. is a gene therapy company that engages in the R&D of new drugs for neurodegenerative diseases. The company has three offices in Shanghai China, Suzhou China, and Philadelphia US. The Philadelphia US was established in 2016, and in 2019, it established China and American team.
In 2021, it signed an agreement of USD 190 million with Spark Therapeutics. In May 2023, NeuExcell Therapeutics Inc. raised over USD 15 million in pre-series A+ funding from new investors China Science and Techinnovation Capital Management, HSCAPITAL, HX Pharma, Jiangxi Jimin Kexin Pharmaceutical Industry Investment, Jinkong Fund Management, Shanghai Zhangke Lingyi Investment Management Co. , LTD, Suzhou Industrial Park Leader Venture Capital Co.
, Ltd. , and Suzhou Trust. The company provides neural regeneration and repair services to patients primarily to treat damaged brain tissues caused by neurodegenerative conditions including stroke, Huntington's disease, amyotrophic lateral sclerosis (ALS), retinal diseases, Glioma, temporal Lobe epilepsy, traumatic brain injury, Parkinson’s disease (PD), Alzheimer’s disease (AD), and spinal cord injury. And the drug pipelines for stroke, completed candidate optimization, Huntington's disease and ALS is in candidate optimization.
And other drug pipelines has in the drug discovery phase.
Current Investors
Oriza Holdings, YuanBio Venture, Co-Win Ventures
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.neuexcell.com
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
NeuExcell Therapeutics Inc. - employee data
NeuExcell Therapeutics Inc. - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Non-Executive Board Director | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.